ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to ...

A nasal vaccine for COVID-19 – based on technology developed ... “This powerful technology has the potential not only to help control COVID-19 but to reduce the burden of respiratory infections ...

STEM Potential supports you through years 10 and 12 with insightful lectures, subject-specific workshops and a non-residential summer school. STEM Potential is a multi-year programme of activities and ...

THOUSANDS of Brits plagued by constant sneezing, a streaming nose and red, watery eyes could be given a ‘life-changing’ pill on the NHS. The National Institute for Healthcare and Care ...

People in England with a severe dust mite allergy are set to be offered a daily pill on the NHS, it has been announced today ...

The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...

Using water straight from the tap can cause potential ... nasal rinse? While most people can benefit from a nasal rinse, it won’t work if you have severe inflammation in your nose blocking the nasal ...

UNDATED (CNN/CNN Newsource/WKRC) - The FDA just approved a ketamine-derived nasal spray for helping to treat ... by a healthcare provider due to its potential adverse side effects.